Healthcare Specialists Passionate About Innovation

Ms. Gonzalo is a Partner at Oberland Capital. Prior to joining Oberland, she was a Managing Director at Vatera Healthcare Partners where she focused on venture capital and private equity investments in the biopharmaceutical industry. Previously, Ms. Gonzalo was a Managing Director with Essex Woodlands, a healthcare-focused growth equity firm. Ms. Gonzalo previously worked for 12 years in the healthcare group of Warburg Pincus LLC, a global private equity firm. Prior to her tenure at Warburg Pincus, Ms. Gonzalo worked at Goldman, Sachs & Co as an Analyst in the firm's Investment Banking Division and Principal Investment Area. Ms. Gonzalo serves on the Planning Committee and is the former Co-Chair of the Respiratory Innovation Summit, which is hosted by the American Thoracic Society and seeks to unite leading companies, innovators, investors, clinicians and advocacy groups to accelerate innovation in the respiratory space and bring new treatments to patients. Previously, Ms. Gonzalo served as Co-President and board member of the Harvard Business School Healthcare Alumni Association. Ms. Gonzalo earned an M.B.A. from Harvard Business School and an A.B. in Biochemical Sciences from Harvard College.

Mr. Dubinsky is the CFO at Oberland Capital. Prior to joining Oberland Capital, Mr. Dubinsky was a Managing Director and CFO at Siguler Guff & Company, a private equity firm with over $10 billion of assets under management. Mr. Dubinsky oversaw the accounting and client reporting functions of the Firm. Previously, Mr. Dubinsky was a Manager within the Assurance & Advisory Business Services department at Ernst & Young. Mr. Dubinsky holds a B.S. in Accounting from Binghamton University, a State University of New York, and is a Certified Public Accountant in the State of New York.

Ms. Siber is a Principal at Oberland Capital. Prior to joining Oberland Capital, Ms. Siber was a Senior Manager in Corporate Development at Pfizer where she was responsible for evaluating and supporting the execution of the company’s strategic transactions, including M&A and licensing collaborations. Previously, Ms. Siber was an Investment Operations Analyst at Blackstone Alternative Asset Management and an Investment Banking Analyst in the healthcare group at Oppenheimer & Co. Ms. Siber earned her M.B.A. from Columbia Business School and her B.S. in Operations Research & Information Engineering from Cornell University.

Dr. Lauenstein is a Senior Associate at Oberland Capital. Prior to joining Oberland Capital, Dr. Lauenstein was a project leader at The Boston Consulting Group, where he provided strategic management consulting services to pharmaceutical, life science companies and private equity funds. Dr. Lauenstein completed a PhD at the University of Cambridge, focusing on structure and function of innate immunity signaling pathways, and holds an M.Sc. and B.Sc in biochemistry from Ghent University.

Ms. Yang is the Assistant Controller at Oberland Capital. Previously, she was a Manager in the Asset & Wealth Management Assurance practice at PwC. Ms. Yang has over six years of audit and accounting experience in the asset management industry with a focus on alternative investment funds. She received an M.S. and a B.S. in Accounting from the University of Virginia and is a Certified Public Accountant in the State of New York.

Ms. Fischer is an Administrative Assistant at Oberland Capital. Prior to joining Oberland Capital, she worked in Early Childhood Education. Ms. Fischer received her BFA in Acting from Shenandoah Conservatory and is pursuing her MS in Marketing from The Zicklin School of Business at Baruch College.